Risultati per: Dalla presbifagia alla sarcopenia, il trattamento in medicina generale

Inibita proteina che svolge ruolo importante nel danno d’organo

: “Non possiamo che accogliere con favore quanto emerso dal Comitato tecnico area assistenza territoriale della Commissione salute del Ministero”

L’Assimefac annuncia la pubblicazione della guida per i medici di medicina generale in merito alla terapia domiciliare del paziente Sars-Cov-2.

A Genova. Per un malore improvviso

Objectives
To examine the positive rate of sarcopenia using the ‘Yubi-wakka’ (finger-ring) test and associated risk factors among adults aged 65 years and older.

Design
Cross-sectional study.

Setting
We used the Yubi-wakka test, which has been developed and validated as a predictor of sarcopenia, frailty, disability and mortality. A positive test result is indicated by a smaller calf circumference than the finger-ring. The test was administered during annual health check-ups among residents of Tama City, Japan.

Participants
During the 2019 fiscal year, 12 894 individuals aged 65 years and older underwent the Yubi-wakka test at primary care clinics.

Interventions
Examinees conducted the test themselves in a seated position. They formed a ring around their calf using both thumbs and index fingers and judged whether their calf was larger, the same or smaller than their finger-ring.

Primary and secondary outcome measures
We compared anthropometric and serological data between the positive (smaller calf) and negative (larger calf) test result groups.

Results
The positive rate was 15.4% among men and 18.5% among women. The prevalence of a positive result was higher in those aged ≥80 years than in younger age groups in both sexes (men: 22.8%; women: 28.8%). Multivariate logistic regression analysis showed that a diagnosis of metabolic syndrome was a risk factor for detecting a positive test result in women aged 65–74 years (OR 3.445; 95% CI 1.44 to 8.29) and ≥75 years (OR 3.37; 95% CI 1.97 to 5.78).

Conclusions
Because the Japanese population is healthy and lives long, interventions against sarcopenia are important, especially for older adults aged >75 years. The presence of metabolic syndrome may be a risk factor for sarcopenia (as detected by the Yubi-wakka test) and future frailty, and requires closer attention, especially among women.

Pubblicato oggi in GU il bando nazionale per il concorso di formazione in medicina generale, Silvestro Scotti (Fimmg): «Risposta immediata del ministero sia d’esempio a Regioni e Governo per eliminare burocrazia, definire Atto d’Indirizzo ACN 2019-21, e per provvedimenti in Finanziaria equi per la convenzionata»

Pubblicato oggi in GU il bando nazionale per il concorso di formazione in medicina generale, Silvestro Scotti (Fimmg): «Risposta immediata del ministero sia d’esempio a Regioni e Governo per eliminare burocrazia, definire Atto d’Indirizzo ACN 2019-21, e per provvedimenti in Finanziaria equi per la convenzionata»

Pubblicato oggi in GU il bando nazionale per il concorso di formazione in medicina generale, Silvestro Scotti (Fimmg): «Risposta immediata del ministero sia d’esempio a Regioni e Governo per eliminare burocrazia, definire Atto d’Indirizzo ACN 2019-21, e per provvedimenti in Finanziaria equi per la convenzionata»

Objectives
To determine the prevalence of possible sarcopenia and its association with other conditions in older adults in Bengbu, China.

Design, setting and participants
A cross-sectional study of 1082 community-dwelling Chinese people aged at least 60 years from March to June 2022.

Methods
Handgrip strength and information regarding associated conditions were collected. Possible sarcopenia was estimated based on handgrip strength with cut-off values (

Per neoplasia a grandi cellule b recidivante o refrattaria

Introduction
Heart failure with preserved ejection fraction (HFpEF) affects more than half of the patients with heart failure. HFpEF and sarcopenia can interact with each other and contribute to reduced physiological function and increased mortality in elderly patients. Resistance training (RT) or resistance exercise rehabilitation (RER) may have benefits for elderly HFpEF patients with sarcopenia. Whey protein supplementation (WPS) may increase the effects of exercise on strength and muscle mass, in addition to promoting heart function and quality of life (QoL). However, studies are needed to evaluate effects of RER and WPS in patients with HFpEF with sarcopenia.

Methods and analysis
This is a prospective, randomised, controlled clinical trial in which patients with HFpEF with sarcopenia will be randomly allocated to three groups, control, RT and RT+WP. Participants in all groups will receive basic intervention including standard medicine treatment, home-based aerobic exercise and basic nutritional intervention. The RT group will undergo resistance exercise programmes, and the RT+WP group will receive daily WPS apart from resistance exercise. The study variables will be evaluated at baseline and 12 weeks. Primary outcome measure is the change of 6 min walking distance. Secondary outcomes include parameters of muscle status, cardiac function, nutritional status, QoL and major adverse cardiovascular events. The primary efficacy analysis will follow the intention-to-treat principle.

Ethics and dissemination
This study was approved by Ethics Committee of China-Japan Friendship Hospital for Clinical Research (No. 2022-KY-003). The results of this study will be disseminated via peer-reviewed publications and presentations at conferences.

Trial registration number
ChiCTR2200061069.